Oncology

Back to articles

Benefits of denosumab for bone metastases in advanced breast cancer

KEY POINT

According to a study recently published in the Journal of Clinical Oncology, denosumab is superior to zoledronic acid in preventing skeletal-related events and renal toxicity in patients with advanced breast cancer who have bone metastases.